Cargando…

Six Weeks of Daily Abaloparatide Treatment Increased Vertebral and Femoral Bone Mineral Density, Microarchitecture and Strength in Ovariectomized Osteopenic Rats

Abaloparatide is a novel, potent and selective activator of parathyroid hormone receptor 1 (PTHR1) under clinical development for the treatment of osteoporosis. We assessed the effect of 6 weeks of abaloparatide on bone mass, microarchitecture, quality and strength in ovariectomized (OVX) rats. Afte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bahar, Hila, Gallacher, Kyla, Downall, Julie, Nelson, Carol A., Shomali, Maysoun, Hattersley, Gary
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055567/ https://www.ncbi.nlm.nih.gov/pubmed/27395059 http://dx.doi.org/10.1007/s00223-016-0171-1

Ejemplares similares

Abaloparatide increases bone mineral density and bone strength in ovariectomized rabbits with glucocorticoid-induced osteopenia
por: Chandler, H., et al.
Publicado: (2019)

Abaloparatide-SC improves trabecular microarchitecture as assessed by trabecular bone score (TBS): a 24-week randomized clinical trial
por: Bilezikian, J. P., et al.
Publicado: (2017)

Intermittent parathyroid hormone improve bone microarchitecture of the mandible and femoral head in ovariectomized rats
por: Chen, Ying-Ju, et al.
Publicado: (2017)

Cortical Bone Morphological and Trabecular Bone Microarchitectural Changes in the Mandible and Femoral Neck of Ovariectomized Rats
por: Hsu, Pei-Yu, et al.
Publicado: (2016)

Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis
por: Watts, N.B., et al.
Publicado: (2019)

Correction to: Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis
por: Watts, N. B., et al.
Publicado: (2020)

Correction to: Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis
por: Watts, N. B., et al.
Publicado: (2020)

Anti-Inflammatory Activity of Water-Soluble Polysaccharide of Agaricus blazei Murill on Ovariectomized Osteopenic Rats
por: Wang, Peng, et al.
Publicado: (2013)

Abaloparatide, a novel PTH receptor agonist, increased bone mass and strength in ovariectomized cynomolgus monkeys by increasing bone formation without increasing bone resorption
por: Doyle, N., et al.
Publicado: (2017)

Phase 1b Evaluation of Abaloparatide Solid Microstructured Transdermal System (Abaloparatide-sMTS) in Postmenopausal Women with Low Bone Mineral Density
por: Miller, Paul D., et al.
Publicado: (2021)

Genetic Dissection of Femoral and Tibial Microarchitecture
por: Lu, Lu, et al.
Publicado: (2019)

Retraction: Therapeutic effect of risedronate on cancellous and cortical bone in ovariectomized osteopenic rats: a comparison with the effects of alfacalcidol.
por: IWAMOTO, Jun, et al.
Publicado: (2018)

Geography of Fracture Incidence in Postmenopausal Women with Osteoporosis Treated with Abaloparatide
por: McClung, Michael R., et al.
Publicado: (2017)

Effects of Spaceflight on Bone Microarchitecture in the Axial and Appendicular Skeleton in Growing Ovariectomized Rats
por: Keune, Jessica A., et al.
Publicado: (2015)

Microarchitectural changes in the mandibles of ovariectomized rats: a systematic review and meta-analysis
por: Lee, Jeong-Hee, et al.
Publicado: (2019)

Effect of combined treatment with alendronate and calcitriol on femoral neck strength in osteopenic rats
por: Nakamura, Yoshinari, et al.
Publicado: (2008)

Correction to: Geography of Fracture Incidence in Postmenopausal Women with Osteoporosis Treated with Abaloparatide
por: McClung, Michael R., et al.
Publicado: (2018)

Effect of Abaloparatide vs Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis
por: Leder, Benjamin Z, et al.
Publicado: (2019)

Bone Microarchitecture and Biomechanics of the Necrotic Femoral Head
por: Ma, Jian-xiong, et al.
Publicado: (2017)

Fracture and Bone Mineral Density Response by Baseline Risk in Patients Treated With Abaloparatide Followed by Alendronate: Results From the Phase 3 ACTIVExtend Trial
por: Leder, Benjamin Z, et al.
Publicado: (2019)

Three-Times-Weekly Administration of Teriparatide Improves Vertebral and Peripheral Bone Density, Microarchitecture, and Mechanical Properties Without Accelerating Bone Resorption in Ovariectomized Rats
por: Takao-Kawabata, Ryoko, et al.
Publicado: (2015)

Bone mineral density changes in osteoporotic and osteopenic patients after COVID-19 infection
por: Elmedany, Samah Hamdy, et al.
Publicado: (2022)

RAD1901: a novel, orally bioavailable selective estrogen receptor degrader that demonstrates antitumor activity in breast cancer xenograft models
por: Garner, Fiona, et al.
Publicado: (2015)

Age-Related Changes in Femoral Head Trabecular Microarchitecture
por: Greenwood, Charlene, et al.
Publicado: (2018)

Bone microarchitecture and bone mineral density in Graves’ disease
por: Boro, Hiya, et al.
Publicado: (2023)

Abaloparatide for risk reduction of nonvertebral and vertebral fractures in postmenopausal women with osteoporosis: a network meta-analysis
por: Reginster, J. -Y., et al.
Publicado: (2019)

Response rates for hip, femoral neck, and lumbar spine bone mineral density in patients treated with abaloparatide followed by alendronate: Results from phase 3 ACTIVExtend
por: Deal, Chad L., et al.
Publicado: (2019)

Abaloparatide and the Spine: A Narrative Review
por: Thompson, Jeremy C, et al.
Publicado: (2020)

Is decreased bone mineral density associated with development of scoliosis? A bipedal osteopenic rat model
por: Dede, Ozgur, et al.
Publicado: (2011)

Cervical spinal instability causes vertebral microarchitecture change and vertebral endplate lesion in rats
por: Liu, Qi, et al.
Publicado: (2019)

Microarchitecture Influences Microdamage Accumulation in Human Vertebral Trabecular Bone
por: Arlot, Monique E, et al.
Publicado: (2008)

Moderate-Intensity Exercise Preserves Bone Mineral Density and Improves Femoral Trabecular Bone Microarchitecture in Middle-Aged Mice
por: Lee, Seungyong, et al.
Publicado: (2022)

Liposomal Encapsulation for Systemic Delivery of Propranolol via Transdermal Iontophoresis Improves Bone Microarchitecture in Ovariectomized Rats
por: Teong, Benjamin, et al.
Publicado: (2017)

Short-term glucocorticoid excess blunts abaloparatide-induced increase in femoral bone mass and strength in mice
por: Brent, Mikkel Bo, et al.
Publicado: (2021)

Abaloparatide is an Effective Treatment Option for Postmenopausal Osteoporosis: Review of the Number Needed to Treat Compared with Teriparatide
por: Reginster, Jean-Yves, et al.
Publicado: (2018)

OR03-1 The Effect of Abaloparatide on Bone Mineral Density and Fracture Incidence in Postmenopausal Women with Osteoporosis and Osteoarthritis
por: Lane, Nancy, et al.
Publicado: (2019)

Dried plum consumption improves bone mineral density in osteopenic postmenopausal woman: A case report
por: Strock, Nicole C.A., et al.
Publicado: (2021)

Abaloparatide Real‐World Patient Experience Study
por: Gold, Deborah T, et al.
Publicado: (2021)

Comparison of vertebral and femoral bone mineral density in adult females
por: Choe, Han Seong, et al.
Publicado: (2016)

ACTIVExtend: 24 Months of Alendronate After 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis
por: Bone, Henry G, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1anovd8gcadagt37bj5t5nnnjg